Article Details

Cabaletta Bio Announces FDA Granted Orphan Drug Designation - GlobeNewswire

Retrieved on: 2024-02-01 21:31:15

Tags for this article:

Click the tags to see associated articles and topics

Cabaletta Bio Announces FDA Granted Orphan Drug Designation - GlobeNewswire. View article details on hiswai:

Excerpt

“CABA-201 is designed to deeply and transiently deplete CD19-positive B cells, which may enable an immune system reset, and has the potential to ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo